Research Article
Achalasia—An Autoimmune Inflammatory Disease: A Cross-Sectional Study
Table 1
Demographic, clinical, and laboratory variables.
| | Blood healthy donors | Tissue control group | Type I achalasia | Type II achalasia | Type III achalasia | (n = 20) | (n = 5) | (n = 8) | (n = 19) | (n = 5) |
| Age (years), mean ± SD | 40.8 ± 10.1 | 72.2 ± 8.9 | 44.2 ± 14.2 | 45.6 ± 16.3 | 45.0 ± 17.4 | Sex, female/male | 12/8 | 4/1 | 4/4 | 12/7 | 4/1 | Disease evolution (months), mean ± SD | ND | ND | 43.7 ± 12.2 | 36.9 ± 7.9 | 69.0 ± 35.8 | Dysphagia (%) | ND | ND | 100 | 95 | 100 | Regurgitation (%) | ND | ND | 86 | 94 | 80 | Weight loss (%) | ND | ND | 71 | 78 | 100 | Pyrosis (%) | ND | ND | 57 | 42 | 40 | Other autoimmune diseases (%) | ND | ND | 0 | 11 | | ESR >20 mmHg (%) | ND | ND | 17 | 25 | 20 |
|
|
; ND: Not determined.
|